BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2350140)

  • 1. [Adrenoleukodystrophy: significance for genetic counseling of the determination of very long-chain fatty acids and of molecular biology].
    Mathieu M; Aubourg P; Guidoux S; Epelbaum S; Benhamou P; Berquin P; Boudailliez B; Piussan C
    Ann Pediatr (Paris); 1990 Mar; 37(3):157-61. PubMed ID: 2350140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkage of adrenoleukodystrophy to a polymorphic DNA probe.
    Aubourg PR; Sack GH; Meyers DA; Lease JJ; Moser HW
    Ann Neurol; 1987 Apr; 21(4):349-52. PubMed ID: 2883927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenoleukodystrophy: from bedside to molecular biology.
    Moser HW
    J Child Neurol; 1987 Apr; 2(2):140-50. PubMed ID: 3598142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial spinocerebellar degeneration as an expression of adrenoleukodystrophy.
    Kobayashi T; Noda S; Umezaki H; Goto I; Suzuki S; Kitaguchi T; Kuroiwa Y
    J Neurol Neurosurg Psychiatry; 1986 Dec; 49(12):1438-40. PubMed ID: 3468205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Familial adrenoleukodystrophy].
    Le Fur JM; Le Meur F; Parent P; Toudic L; Castel Y
    J Genet Hum; 1985 Dec; 33(5):427-34. PubMed ID: 4093772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype heterogeneity among hemizygotes in a family biochemically screened for adrenoleukodystrophy.
    Cotrufo R; Melone MA; Monsurro MR; Di Iorio G; Carella C; Moser HW
    Am J Med Genet; 1987 Apr; 26(4):833-8. PubMed ID: 3591825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apropos of a familial case of adrenoleukodystrophy related to X chromosome diagnosed prenatally].
    Parent P; Le Meur F; Alix D; Le Fur JM; Toudic L; Castel Y
    Pediatrie; 1987; 42(4):297-301. PubMed ID: 3671029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier detection in X-linked adrenoleukodystrophy by determination of very long chain fatty acid levels and by linkage analysis.
    Notarangelo LD; Parolini O; Baiguini G; Buzi F; Paterlini C; Perini A; Rimoldi M; Tiberti S; Uziel G; Notarangelo L
    Eur J Pediatr; 1992 Oct; 151(10):761-3. PubMed ID: 1425799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial adrenoleukodystrophy: long chain fatty acid levels and analysis with a factor VIII DNA probe.
    Berriche S; Turpin JC; Lucotte G
    J Neurol; 1988 Mar; 235(4):234-5. PubMed ID: 2897431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenoleukodystrophy: biochemical procedures in diagnosis, prevention and treatment.
    Watkins PA; Naidu S; Moser HW
    J Inherit Metab Dis; 1987; 10 Suppl 1():46-53. PubMed ID: 3119941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenoleukodystrophy: manifestations of a protean disorder: report of a recently identified kindred.
    Chancellor AM; Glasgow GL; Lambie NK; Synek BJ
    N Z Med J; 1989 May; 102(867):220-2. PubMed ID: 2717104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Spastic paraparesis and adrenal gland insufficiency: adrenomyeloneuropathy].
    Zijlmans JM; van Marion WF
    Ned Tijdschr Geneeskd; 1987 Jan; 131(5):208-11. PubMed ID: 3822010
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of female carriers of adrenoleukodystrophy.
    Moser HW; Moser AE; Trojak JE; Supplee SW
    J Pediatr; 1983 Jul; 103(1):54-9. PubMed ID: 6864396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First trimester prenatal diagnosis of adrenoleukodystrophy by determination of very long chain fatty acid levels and by linkage analysis to a DNA probe.
    Boué J; Oberle I; Heilig R; Mandel JL; Moser A; Moser H; Larsen JW; Dumez Y; Boué A
    Hum Genet; 1985; 69(3):272-4. PubMed ID: 3856557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenoleukodystrophy: a genetic, clinical, biochemical and computed tomographic study of four patients in three different families.
    Dotti MT; Annunziata P; D'Amore I; Terrosi Vagnoli P; Venturi C; Federico A
    Acta Neurol (Napoli); 1987 Jun; 9(3):178-90. PubMed ID: 3630789
    [No Abstract]   [Full Text] [Related]  

  • 16. Adrenoleukodystrophy in Israel: a genetic, clinical and biochemical study.
    Chemke J; Lieberman E; Carmi R; Abarbanel Y; Costeff H; Goldhammer Y; Moser HW
    Isr J Med Sci; 1984 Dec; 20(12):1123-32. PubMed ID: 6097565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenoleukodystrophy presenting as spinocerebellar degeneration.
    Nakazato T; Sato T; Nakamura T; Tsuji S; Narabayashi H
    Eur Neurol; 1989; 29(4):229-34. PubMed ID: 2547619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma polyenoic very-long-chain fatty acids in peroxisomal disease: biochemical discrimination of Zellweger's syndrome from other phenotypes.
    Poulos A; Sharp P; Johnson D
    Neurology; 1989 Jan; 39(1):44-7. PubMed ID: 2462697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Familial spastic paraparesis: phenotypic variant of adrenoleukodystrophy].
    de Andrés C; Giménez-Roldán S
    Neurologia; 1990 Jan; 5(1):24-8. PubMed ID: 2361026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkage of DNA markers at Xq28 to adrenoleukodystrophy and adrenomyeloneuropathy present within the same family.
    Willems PJ; Vits L; Wanders RJ; Coucke PJ; Van der Auwera BJ; Van Elsen AF; Raeymaekers P; Van Broeckhoven C; Schutgens RB; Dacremont G
    Arch Neurol; 1990 Jun; 47(6):665-9. PubMed ID: 2161209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.